Virios Therapeutics, Inc.

  • About Virios
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Corporate Presentation
  • Target Diseases
    • Fibromyalgia
    • Long Covid
    • Blog
  • Pipeline
    • Pipeline
    • Presentations and Publications
  • Investors
  • News
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News
    • Press Releases
    • Email Alerts
  • Events & Presentations
    • Events
    • Presentations
    • Shareholder Letters
    • Meeting
  • Governance
    • Overview
    • Leadership
    • Board of Directors
    • Board Committees
    • Governance Documents
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Financial & Stock Info
    • Overview
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • Resources
    • Overview
    • IR Contacts
    • FAQ
    • Email Alerts
  • News

  • Press Releases
  • Email Alerts
Mar 14, 2023 7:05am EDT

Virios Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results

Mar 07, 2023 7:05am EST

Virios Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 14, 2023

Feb 13, 2023 7:05am EST

Virios Therapeutics Announces Exploratory Long-COVID Trial Top-Line Data, Featuring Combination of Valacyclovir and Celecoxib, Projected in June 2023

Jan 05, 2023 7:00am EST

Virios Therapeutics Announces Scheduling of FDA Meeting in March 2023 to Discuss IMC-1 Fibromyalgia Phase 3 Program

Nov 29, 2022 7:05am EST

Virios Therapeutics, Inc. to Present at the Virtual Planet MicroCap Showcase

Nov 14, 2022 7:05am EST

Virios Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update

Nov 03, 2022 7:05am EDT

Virios Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update on Monday, November 14, 2022

Sep 22, 2022 4:15pm EDT

Virios Therapeutics, Inc. Announces Closing of Public Offering

Sep 19, 2022 10:04pm EDT

Virios Therapeutics, Inc. Announces Pricing of Public Offering

Sep 19, 2022 4:05pm EDT

Virios Therapeutics, Inc. Announces Proposed Public Offering

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed

© 2023 Virios Therapeutics, Inc.           Terms and Conditions Privacy Policy Social Media Guidelines